Elite Pharmaceuticals Inc (ELTP)
0.1298
0.00 (0.00%)
USD |
OTCM |
May 03, 14:35
Elite Pharmaceuticals 1 Year Total Returns (Daily): 282.8% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 02, 2024 | 282.8% |
| May 01, 2024 | 277.6% |
| April 30, 2024 | 293.0% |
| April 29, 2024 | 309.1% |
| April 26, 2024 | 318.0% |
| April 25, 2024 | 271.1% |
| April 24, 2024 | 307.4% |
| April 23, 2024 | 291.1% |
| April 22, 2024 | 303.8% |
| April 19, 2024 | 338.4% |
| April 18, 2024 | 330.6% |
| April 17, 2024 | 343.1% |
| April 16, 2024 | 336.3% |
| April 15, 2024 | 335.5% |
| April 12, 2024 | 382.8% |
| April 11, 2024 | 374.2% |
| April 10, 2024 | 376.9% |
| April 09, 2024 | 373.8% |
| April 08, 2024 | 366.4% |
| April 05, 2024 | 366.7% |
| April 04, 2024 | 344.5% |
| April 03, 2024 | 376.2% |
| April 02, 2024 | 427.6% |
| April 01, 2024 | 427.6% |
| March 28, 2024 | 406.0% |
| Date | Value |
|---|---|
| March 27, 2024 | 415.2% |
| March 26, 2024 | 402.0% |
| March 25, 2024 | 400.2% |
| March 22, 2024 | 384.8% |
| March 21, 2024 | 382.4% |
| March 20, 2024 | 365.6% |
| March 19, 2024 | 351.1% |
| March 18, 2024 | 357.1% |
| March 15, 2024 | 357.1% |
| March 14, 2024 | 384.3% |
| March 13, 2024 | 332.8% |
| March 12, 2024 | 322.0% |
| March 11, 2024 | 357.0% |
| March 08, 2024 | 408.4% |
| March 07, 2024 | 381.2% |
| March 06, 2024 | 363.9% |
| March 05, 2024 | 351.3% |
| March 04, 2024 | 374.7% |
| March 01, 2024 | 370.6% |
| February 29, 2024 | 363.2% |
| February 28, 2024 | 353.7% |
| February 27, 2024 | 345.3% |
| February 26, 2024 | 364.5% |
| February 23, 2024 | 311.1% |
| February 22, 2024 | 351.4% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-61.97%
Minimum
Aug 05 2019
556.0%
Maximum
Jan 18 2024
28.14%
Average
-15.58%
Median
1 Year Total Returns (Daily) Benchmarks
| NovaBay Pharmaceuticals Inc | -91.96% |
| Palatin Technologies Inc | -6.82% |
| iBio Inc | -90.77% |
| Theriva Biologics Inc | -37.61% |
| Oragenics Inc | -62.50% |